ST. LOUIS, Oct. 28 /PRNewswire-FirstCall/ -- Centene Corporation (NYSE: CNC) today announced it will present at two upcoming healthcare conferences in November.
At the Oppenheimer 21st Annual Healthcare Conference, to be held November 2-3, 2010, at the Waldorf-Astoria in New York City, Centene is scheduled to present on Wednesday, November 3rd, at 2:10 PM Eastern Time. Investors and other interested parties unable to attend the presentation can access a live audio webcast at: http://www.veracast.com/webcasts/opco/healthcare2010/63210285.cfm.
The following week, Centene will participate in the Credit Suisse 2010 Annual Healthcare Conference, to be held November 10-12, 2010 at the Arizona Biltmore in Phoenix. Centene's presentation is set for Thursday, November 11th, at 2:30 PM Mountain Standard Time. A live audio webcast is available at: http://cc.talkpoint.com/cred001/111010a_rb/?entity=50_QV58JK7.
A webcast replay will be available shortly after each presentation via the Company's website at www.centene.com under the Investors section.
About Centene Corporation
Centene Corporation, a Fortune 500 company, is a leading multi-line healthcare enterprise that provides programs and related services to the rising number of under-insured and uninsured individuals. Many receive benefits provided under Medicaid, including the Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care, long-term care, other state-sponsored programs and Medicare (Special Needs Plans). Centene's CeltiCare subsidiary offers states unique "exchange-based" and other cost-effective coverage solutions for low-income populations. The Company operates local health plans and offers a range of health insurance solutions. It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health, life and health management, managed vision, telehealth services, and pharmacy benefits management. More information regarding Centene is available at www.centene.com.
SOURCE Centene Corporation